Translational Development Acquisition (TDAC) Selling, General & Administrative (2024 - 2026)
Translational Development Acquisition (TDAC) Selling, General & Administrative (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 124,777.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 194,528.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 112,227.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 144,182.00 |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 1.47 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 115,742.00 |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 96,300.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | - |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 390,784.00 |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | 661,050.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,161.00 |
| Dec 31, 2025 | 162,345.00 |
| Sep 30, 2025 | 213,658.00 |
| Jun 30, 2025 | 221,127.00 |
| Mar 31, 2025 | 347,408.00 |
| Dec 31, 2024 | 133,390.00 |
| Sep 30, 2024 | 61,283.00 |